Skip to content

13F-HR filed by Rhenman & Partners Asset Management AB

Rhenman & Partners Asset Management AB filed this 13F-HR for the quarter ended 2015-03-31, filed 2015-05-13, with 89 holding rows worth $593,072,000.

Accession
0001415889-15-001643
Filed
2015-05-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2015

A holdings report, 89 entries on the cover page, a total value of $593,072,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $593,072,000 with VALUE read as thousands by filing date, 13F file number 028-15944. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SELECT SECTOR SPDR TR81369Y961OPT440,000$31,900,000thousands by filing dateput
ALEXION PHARMACEUTICALS INC015351109COM114,978$19,926,000thousands by filing date
CELGENE CORP151020104COM151,000$17,407,000thousands by filing date
Merck & Co.,Inc.58933Y105COM300,000$17,244,000thousands by filing date
BIOGEN INC COM09062X103Stock40,700$17,185,000thousands by filing date
Amgen Inc.031162100COM99,000$15,825,000thousands by filing date
ALKERMES PLCG01767105SHS258,000$15,730,000thousands by filing date
Gilead Sciences,Inc.375558103COM159,000$15,603,000thousands by filing date
UnitedHealth Group Inc91324P102COM130,000$15,378,000thousands by filing date
CVS Health Corporation126650100COM145,000$14,965,000thousands by filing date
ACTAVIS PLCG0083B108SHS45,300$13,482,000thousands by filing date
AbbVie,Inc.00287Y109COM220,000$12,879,000thousands by filing date
CARDINAL HEALTH INC14149Y108COM141,400$12,764,000thousands by filing date
ESPERION THERAPEUTICS INC NEW COM29664W105Stock126,926$11,753,000thousands by filing date
RITEAID CORP767754104COM1,276,462$11,092,000thousands by filing date
INCYTE CORP COM45337C102Stock120,000$10,999,000thousands by filing date
NEKTAR THERAPEUTICS640268108COM996,600$10,963,000thousands by filing date
UNIVERSAL HLTH SVCS INC CL B913903100Stock87,000$10,241,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock22,000$9,933,000thousands by filing date
JAZZ PHARMACEUTICALS PLC SHS USDG50871105Stock55,000$9,503,000thousands by filing date
Eli Lilly and Company532457108COM129,000$9,372,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM75,000$9,347,000thousands by filing date
MEDIVATION INC58501N101COM69,000$8,906,000thousands by filing date
Anthem Inc.36752103 COM57,000$8,801,000thousands by filing dateThe CUSIP as filed is malformed.
MCKESSON CORP COM58155Q103Stock38,000$8,596,000thousands by filing date
Bristol-Myers Squibb Company110122108COM129,000$8,321,000thousands by filing date
RECEPTOS, INC.756207106COMMON STOCK43,500$7,173,000thousands by filing date
VALEANT PHARMACEUTICALS INTL91911K102COM36,000$7,150,000thousands by filing date
CYBERONICS23251P102COMMON STOCK108,000$7,011,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM58,000$6,842,000thousands by filing date
Becton Dickinson75887109 COM46,982$6,746,000thousands by filing dateThe CUSIP as filed is malformed.
OREXIGEN THERAPEUTICS INC686164104COMMON STOCK831,800$6,513,000thousands by filing date
ISIS PHARMACEUTICALS INC464330109COM102,000$6,494,000thousands by filing date
INTERCEPT PHARMACEUTICALS IN45845P108COM23,000$6,486,000thousands by filing date
CEMPRA INC15130J109COM185,300$6,358,000thousands by filing date
COMMUNITY HEALTH SYSTEMS INC203668108COMMON STOCK118,000$6,169,000thousands by filing date
ACADIA PHARMACEUTICALS INC004225108COM171,000$5,573,000thousands by filing date
HCA Healthcare Inc40412C101COM74,000$5,567,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock53,000$5,534,000thousands by filing date
SUPERNUS PHARMACEUTICALS868459108COM450,800$5,450,000thousands by filing date
MEDTRONIC INC585055106COM69,000$5,381,000thousands by filing date
LABORATORY CORP OF AMERICA50540R409COM NEW39,000$4,918,000thousands by filing date
REVANCE THERAPEUTICS INC761330109COM236,000$4,892,000thousands by filing date
CERNER CORP156782104COM66,000$4,835,000thousands by filing date
DEXCOM INC COM252131107Stock77,000$4,800,000thousands by filing date
AMSURG CORP03232P405COM76,000$4,676,000thousands by filing date
TETRAPHASE PHARMACEUTICALS INC88165N105COMMON STOCK122,000$4,470,000thousands by filing date
INTRA-CELLULAR THERAPIES INC46116X101COMMON STOCK183,000$4,370,000thousands by filing date
AETNA INC NEW00817Y108COM41,000$4,368,000thousands by filing date
CENCORA INC COM03073E105Stock38,000$4,319,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM54,000$4,008,000thousands by filing date
ABIOMED INC003654100COM55,000$3,937,000thousands by filing date
OMNICARE INC681904108COM50,000$3,853,000thousands by filing date
KERYX BIOPHARMACEUTICALS492515101COMMON STOCK297,000$3,781,000thousands by filing date
THORATEC CORP885175307COM87,000$3,644,000thousands by filing date
RIGEL PHARMACEUTICALS INC766559603COMMON STOCK1,000,000$3,570,000thousands by filing date
CENTENE CORP DEL COM15135B101Stock48,000$3,393,000thousands by filing date
HOLOGIC INC436440101COM101,000$3,336,000thousands by filing date
MACROGENICS INC556099109COM106,000$3,325,000thousands by filing date
CELLDEX THERAPEUTICS INC NEW15117B103COM119,000$3,317,000thousands by filing date
ENDOLOGIX INC29266S106COM194,000$3,312,000thousands by filing date
PERRIGO CO PLC SHSG97822103Stock20,000$3,311,000thousands by filing date
ST JUDE MED INC790849103COM48,800$3,192,000thousands by filing date
ARIAD PHARMACEUTICALS INC04033A100COM387,000$3,189,000thousands by filing date
ANTHERA PHARMACEUTCLS INC03674U201Common equity shares701,314$3,135,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR50,000$3,115,000thousands by filing date
TESARO INC881569107COM52,999$3,042,000thousands by filing date
LIGAND PHARMACEUTICALS INC53220K504COM NEW39,000$3,007,000thousands by filing date
INSULET CORP COM45784P101Stock90,000$3,002,000thousands by filing date
CEPHEID15670R107COM52,000$2,959,000thousands by filing date
Stryker Corporation863667101COM32,000$2,952,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock400,000$2,948,000thousands by filing date
XENCOR INC98401F105COMMON STOCK190,000$2,911,000thousands by filing date
HEARTWARE INTERNATIONAL422368AA8NOTE33,000$2,896,000thousands by filing date
OMNICELL COM COM68213N109Stock80,000$2,808,000thousands by filing date
ACHILLION PHARMACEUTICALS IN00448Q201COM280,000$2,761,000thousands by filing date
DYNAVAX TECHNOLOGIES CORP268158102COM122,835$2,755,000thousands by filing date
EDWARDS LIFESCIENCES CORP COM28176E108Stock19,000$2,707,000thousands by filing date
Tandem Diabetes Care, Inc.875372104COM209,000$2,638,000thousands by filing date
KITE PHARMA INC49803L109COM45,000$2,596,000thousands by filing date
ENDO INTL PLCG30401106SHS26,741$2,399,000thousands by filing date
CELLADON CORP15117E107Cmn120,053$2,274,000thousands by filing date
MYRIAD GENETICS INC62855J104COM60,000$2,124,000thousands by filing date
AVALANCHE BIOT05337G107Common Stock43,000$1,742,000thousands by filing date
LEXICON PHARMACEUTICALS INC528872104COM1,594,805$1,506,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM45,388$1,331,000thousands by filing date
THRESHOLD PHARMACEUTICAL INC885807206COM NEW201,537$818,000thousands by filing date
BIND THERAPEUTICS INC05548N107Cmn133,535$733,000thousands by filing date
CHIMERIX INC COM16934W106Stock14,200$535,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001415889-15-001643this filing2015-05-13acceptance time not in the bulk data set